198HO02236 DIONIGI PP

Print/PDF
Registration Name SANTANTONIO IRONGEN DIONIGI-ET
Registration Number HOITA019992003011
Primary NAAB Code 198HO02236
Secondary Code(s) 598HO02236
Status Inactive
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 2/18/2020
aAa 324156
DMS -
GFI 12.3%
Genetic Codes * TY TC PP TV TL TR TD TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HHP-A
Sire WILDER HOTSPOT P-ET
MGS ENDCO SUPERHERO-ET
Beta Casein A1A2
Kappa Casein AE
Beta Lactoglobulin AA
INDEXES
NM$ -1, 80% R CM$ 5
NM Percentile 16% FM$ -16
GTPI 2559 GM$ 23
PRODUCTION TRAITS
216 Dtrs 120 herds 0 % US 88% R
Milk 330 Fat, % -14 , -0.10%
SCS 3.07, 87% R Protein, % 15 , +0.02%
Feed Saved -44 , 53% R Milking Speed 7.19 , 65% R
Health & Fertility
Productive Life 0.5      81% R Mastitis 0.8      75% R
Heifer Livability -0.3       55% R Metritis 0.4      70% R
Livability 0.7      77% R D. Abom -0.5      73% R
DPR 1.1      83% R Ketosis 0.4      70% R
HCR 1.1      78% R R. Placenta -0.6      71% R
FSC 4.3      77% R Milk Fever -0.2      63% R
CCR 2.4      82% R
SCR -        -
DIA -0.1      41% R
RSP -0.4      49% R
Calving Traits
Sire CE 1.4      38% R 213 Obs
Daughter CE 1.7      29% R 0 Obs, 87 Dtrs
Sire SB 3.5      33% R 478 Obs
Daughter SB 4.8      36% R 0 Obs, Dtrs
Gestation Length 1.3      77% R 0 Obs, 0 Dtrs
Early First Calving -2.2      75% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
128 Dtrs 80 herds 86% R
PTA Type 0.16 UDC 0.23
HCC 0.66 BWC 0.19
FLC -0.33
Linear Traits
Stature 0.19
Tall
Strength -0.21
Strong
Body Depth -0.05
Shallow
Dairy Form -0.50
Closed
Rump Angle 0.40
Sloped
Thurl Width 0.42
Wide
Rear Legs-Side View -0.44
Straight
Rear Legs-Rear View -0.61
H.-in
Foot Angle -0.74
Low
Feet & Legs Score -0.12
Low
F.U. Attachment 1.53
Strong
Rear Udder Height 0.42
High
Rear Udder Width 0.11
Wide
Udder Cleft -1.14
Weak
Udder Depth 1.43
Shallow
Front Teat Placement -2.06
Wide
Rear Teat Placement -1.86
Wide
Teat Length 2.32
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO